Cargando…

Efficacy of specific immunotherapy of abdominal sepsis

Detalles Bibliográficos
Autores principales:	Butyrsky, Olexandr, Butyrsky, Iryna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952522/ http://dx.doi.org/10.1186/cc12907

Ejemplares similares

Passive immunotherapy of extended peritonitis as abdominal sepsis prevention
por: Butyrsky, Olexandr, et al.
Publicado: (2013)

Anti-endotoxin immunity in abdominal sepsis patients
por: Butyrsky, O, et al.
Publicado: (2011)

Immunoglobulin therapy of abdominal sepsis in emergency surgery
por: Butyrsky, O, et al.
Publicado: (2012)

Abdominal sepsis: efficacy of passive immunotherapy
por: Knut, Ruslan, et al.
Publicado: (2007)

Compartmentalization of the inflammatory response in abdominal sepsis
por: Grigoryev, E
Publicado: (2008)

Severe abdominal sepsis in the intensive care unit
por: Morar, R
Publicado: (2004)

Procalcitonin as prognostic marker in severe sepsis of abdominal origin
por: Gonzalez-Lisorge, A, et al.
Publicado: (2015)

Long-term efficacy of allergen specific immunotherapy in atopic dermatitis patients
por: Wyrzykowska, Nina, et al.
Publicado: (2015)

Epidemiology of ventilator associated pneumonia (vap) in patients with abdominal sepsis
por: Hom Choudhuri, A, et al.
Publicado: (2015)

Different correlations between lymphocyte subsets from patients with intra-abdominal sepsis and pneumonia-derived sepsis
por: Skirecki, TS, et al.
Publicado: (2011)

Serum C-reactive protein concentration in early abdominal and pulmonary sepsis
por: Orati, JA, et al.
Publicado: (2013)

Effects of nitroglycerin on intestinal microcirculatory blood flow in patients with abdominal sepsis
por: Roossien, F, et al.
Publicado: (2010)

Abdominal organs' microcirculation dysfunction sequence in severe sepsis by SDF microscopy and histology
por: Almeida-Filho, J, et al.
Publicado: (2012)

Role of the clarithromycin immune modulator activity on abdominal microhemodynamics and mortality in severe sepsis
por: Jesus, FRE, et al.
Publicado: (2012)

Risk/benefit analysis of activated protein C in patients with intra-abdominal sepsis
por: Borthwick, E, et al.
Publicado: (2007)

Effects of sepsis on respiratory mechanics in a porcine model of intra-abdominal hypertension
por: Fyntanidou, B, et al.
Publicado: (2015)

Neuroaxial catheters following abdominal surgery and their impact on the use of Drotrecogin alfa (activated) in sepsis
por: Steel, A, et al.
Publicado: (2004)

Pre-existing systemic inflammation attenuates bacterial clearance by the liver in porcine abdominal sepsis
por: Hanslin, K, et al.
Publicado: (2015)

Intra-abdominal hypertension as a risk factor of death in patients with severe sepsis or septic shock
por: Reintam, A, et al.
Publicado: (2007)

Cancer-specific T cell receptor isolation for cancer immunotherapy
por: Baker, Debbie Emma, et al.
Publicado: (2015)

Poster 1000: Efficacy and safety of specific sublingual immunotherapy with carbamylated allergoid tablets of ragweed pollen: a dose-ranging study
por: Compalati, Enrico, et al.
Publicado: (2014)

Antithrombin III concentrate therapy may have an efficacy in sepsis
por: Saito, N, et al.
Publicado: (2013)

Intravenous immunoglobulin therapy could have efficacy in severe sepsis
por: Kim, Ahmin, et al.
Publicado: (2013)

Efficacy of the CTR-001 direct hemoperfusion adsorption column in sepsis
por: Suzuki, Y, et al.
Publicado: (2008)

N-terminal pro-BNP predicts mortality better than procalcitonin in abdominal severe sepsis and septic shock
por: Ruiz-Vera, N, et al.
Publicado: (2011)

Efficacy of endotoxin absorption therapy on sepsis by polymyxin B-attached fibers
por: Atagi, K
Publicado: (2011)

Efficacy of corticosteroids on survival in patients with sepsis and septic shock: meta-analysis
por: Uchiyama, N, et al.
Publicado: (2009)

Prevalence of mesquite (prosopis species) allergy and efficacy of conventional allergen specific Immunotherapy (ASIT) to mesquite in Egyptian patients with perennial allergic rhinitis (PAR)
por: Farag-Mahmod, Farag I, et al.
Publicado: (2010)

Cardiac-specific troponin I and cardiovascular dysfunction in post-traumatic sepsis
por: Georgiev, G, et al.
Publicado: (2010)

Food hypersensitivity in patients treated with specific allergen immunotherapy (SIT) for aeroallergens
por: Gocki, J, et al.
Publicado: (2013)

Influence of specific allergy immunotherapy (SIT) for aeroallergens on coexisting food hypersensitivity
por: Gocki, J, et al.
Publicado: (2013)

A retrospective investigation of the pmx-dhp's efficacy in 88 severe sepsis cases
por: Tanaka, M, et al.
Publicado: (2015)

Efficacy and safety of heparin in patients with sepsis: a systematic review and meta-analysis
por: Zarychanski, R, et al.
Publicado: (2015)

Poster 1020: Efficacy and safety of sublingual specific immunotherapy with Pru p 3 in a portuguese population - clinical and immunological evaluation during 12 months
por: Costa, Ana Célia, et al.
Publicado: (2014)

The Cost of Albumin Sepsis Treatment (COAST) study: efficacy analysis of albumin for severe sepsis. Modelling using the SAFE study and CUB-Rea data
por: Guidet, B, et al.
Publicado: (2006)

Quality of life of sepsis survivors: evaluation with a specific critical care questionnaire
por: Granja, C
Publicado: (2004)

Clinical effects of polymyxin B immobilised fiber with direct hemoperfusion for the patients of severe sepsis or septic shock caused by intra-abdominal infections
por: Ikeda, T, et al.
Publicado: (2009)

House dust mite-specific immunotherapy and tropomyosin sensitizations: harm or benefit for patients?
por: Pevec, B, et al.
Publicado: (2013)

Anaphylaxis during specific subcutaneous immunotherapy against ragweed allergen -- case record
por: Prnjavorac, Besim, et al.
Publicado: (2014)

Immunological changes after one year of specific immunotherapy with Pru p 3
por: Gomez, Francisca, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_606plolkbrin8t3hmn2ulj1mh1